Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 1382 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1An overview of statin-induced myopathy and perspectives for the future
Dragana Nikolic,Maciej Banach,Roberta Chianetta,Luca Marco Luzzu,Anca Pantea Stoian,Camelia Cristina Diaconu,Roberto Citarrella,Giuseppe Montalto,Manfredi Rizzo
Expert Opinion on Drug Safety.2020;19(5)601
[DOI]
2Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase
Dirk Essers,Martina Schäublin,Gerd A. Kullak-Ublick,Stefan Weiler
European Journal of Clinical Pharmacology.2019;75(3)409
[DOI]
3Analysis of Safety Issues of Using Statins in Patients with Diabetes and Hypothyroidism
V. V. Arkhipov,G. I. Gorodetskaya,O. A. Demidova,T. V. Alexandrova,A. A. Alexandrov
Safety and Risk of Pharmacotherapy.2019;7(4)163
[DOI]
4The potential of Atorvastatin for chronic lung diseases therapy
Alaa S. Tulbah
Saudi Pharmaceutical Journal.2020;7(4)163
[DOI]
5Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats
Bharti Chogtu,Balaji Ommurugan,Sereen R. Thomson,Sneha G. Kalthur
The Scientific World Journal.2020;2020(4)1
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal